Abstract

Genetic variants at the SORT1 locus in humans, which cause increased SORT1 expression in the liver, are significantly associated with reduced plasma levels of LDL cholesterol and apolipoprotein B (apoB). However, the role of hepatic sortilin remains controversial, as genetic deletion of sortilin in mice has resulted in variable and conflicting effects on apoB secretion. Here, we found that Sort1-KO mice on a chow diet and several Sort1-deficient hepatocyte lines displayed no difference in apoB secretion. When these models were challenged with high-fat diet or ER stress, the loss of Sort1 expression resulted in a significant increase in apoB-100 secretion. Sort1-overexpression studies yielded reciprocal results. Importantly, carriers of SORT1 variant with diabetes had larger decreases in plasma apoB, TG, and VLDL and LDL particle number as compared with people without diabetes with the same variants. We conclude that, under basal nonstressed conditions, loss of sortilin has little effect on hepatocyte apoB secretion, whereas, in the setting of lipid loading or ER stress, sortilin deficiency leads to increased apoB secretion. These results are consistent with the directionality of effect in human genetics studies and suggest that, under stress conditions, hepatic sortilin directs apoB toward lysosomal degradation rather than secretion, potentially serving as a quality control step in the apoB secretion pathway in hepatocytes.

Highlights

  • The protein sortilin, encoded by the gene SORT1, has been of great interest to the genetics and cardiometabolic disease communities over the last decade

  • The experiments described here sought to resolve the conflicting data that has arisen in the literature over the past 10 years about the directionality of sortilin’s effect on apolipoprotein B (apoB)-100 secretion, a topic that has been the subject of numerous reviews [28, 36, 37]

  • We conclude that under basal non-endoplasmic reticulum (ER) stressed conditions, deletion of sortilin has little effect on hepatocyte apoB-100 secretion, but that in the setting of lipid-loading or induced ER stress, reduced hepatic sortilin leads to increased apoB-100 secretion and increased sortilin leads to decreased apoB-100 secretion (Figure 7), a directionality of effect completely consistent with the human genetics data

Read more

Summary

Introduction

The protein sortilin, encoded by the gene SORT1, has been of great interest to the genetics and cardiometabolic disease communities over the last decade. Sortilin is a type I transmembrane multi-ligand receptor that is synthesized as a propeptide in the endoplasmic reticulum (ER) and processed to its mature form in the Golgi It is best known for its role in trafficking proteins from the Golgi to endolysosomal compartments where it deposits cargo targeted for degradation in the lysosome and is trafficked back to the Golgi via the retromer complex [1,2,3,4]. In >300,000 persons [8] the lead SORT1 variant rs12740374 was associated with a 6 mg/dL reduction in LDL-C (p = 1x10-323) and a 11% reduction in risk of CAD (p = 1x10-23) This same variant was significantly associated with a significant decrease in plasma apolipoprotein B (apoB) levels (p

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call